ライフサイエンスコーパス: e-cigarette use

1 trials evaluated effects of interventions on e-cigarette use.

2 ee (50%) of whom had relapsed with vaping or e-cigarette use.

3 arette dual use, and a decrease in exclusive e-cigarette use.

4 ) of middle school students reported current e-cigarette use.

5 ) of middle school students reported current e-cigarette use.

6 Outcomes were current tobacco smoking and e-cigarette use.

7 be ineffective at preventing youth flavored e-cigarette use.

8 iquids) enhances nicotine bioavailability in e-cigarette use.

9 >30% of high school-age adolescents reported e-cigarette use.

10 usive cigarette use or dual use to exclusive e-cigarette use.

11 4 755 BRFSS participants with information on e-cigarette use.

12 d monthly assessments via text message about e-cigarette use.

13 y and adverse birth outcomes associated with e-cigarette use.

14 ion to identify factors associated with ever e-cigarette use.

15 igarette smoking associated with past 30-day e-cigarette use.

16 d monthly assessments via text message about e-cigarette use.

17 king after initiation regardless of baseline e-cigarette use.

18 of middle school students reported flavored e-cigarette use.

19 past-month prevalence of dual cigarette and e-cigarette use (13.5% vs 10.1%; P = .02), polycombustib

20 Overall, among individuals reporting current e-cigarette use, 42.2% (95% CI, 40.7%-43.7%) indicated f

21 mong 994 307 adults from states with data on e-cigarette use, 429 370 individuals (weighted 51.3% fem

22 y) had significantly higher adjusted odds of e-cigarette use (adjusted odds ratio [AOR], 1.60; 95% CI

23 social media posts was associated with solo e-cigarette use (adjusted odds ratio [AOR], 1.83; 95% CI

24 of e-cigarettes depend, in part, on whether e-cigarette use affects the risk of cigarette smoking.

25 s in this population are not attributable to e-cigarette use alone.

26 Median e-cigarette use also increased from 3 to 5 d/mo in 2014

27 e-cigarette use also increased over time in both the SBI

28 Updated data on the patterns of e-cigarette use among adults in the US are needed.

29 aller increases in the rates of cannabis and e-cigarette use among all female students (cannabis use:

30 aller increases in the rates of cannabis and e-cigarette use among all female students.

31 other substance use, and sensation seeking, e-cigarette use among cannabis-naive adolescents was ass

32 ugust 2022 to assess the association between e-cigarette use among cigarette-naive adolescents aged 1

33 tion between smoking initiation PRS and ever e-cigarette use among never smokers.

34 Studies of e-cigarette use among people without an established smok

35 e cigarettes; however, little is known about e-cigarette use among pregnant adolescents, a population

36 revention has reported a trend of increasing e-cigarette use among teens, with use rates doubling fro

37 With increasing e-cigarette use among US adolescents and decreasing use

38 vertising and parental and peer influence in e-cigarette use among US adolescents in recent years, hi

39 The prevalence of e-cigarette use among US youth increased from 2011 to 20

40 actions are warranted to prevent and reduce e-cigarette use among US youth.

41 ookah use, ever e-cigarette use, and current e-cigarette use) among New Jersey high school students,

42 regressions assessed the association between e-cigarette use and cannabis use 1 year later.

43 The prospective association between e-cigarette use and cannabis use has been less clear, es

44 We aimed to assess the association between e-cigarette use and cigarette smoking cessation among ad

45 the independent association between baseline e-cigarette use and cigarette smoking, controlling for s

46 We assessed the association between e-cigarette use and fecundability, overall and according

47 access source) by school level and flavored e-cigarette use and flavor types among current e-cigaret

48 e clinical findings and associations between e-cigarette use and increased incidence of respiratory d

49 rettes, few studies have evaluated perinatal e-cigarette use and its associated health effects.

50 oportion of individuals who reported current e-cigarette use and never using combustible cigarettes w

51 , which is addictive, raising concerns about e-cigarette use and nicotine addiction in children.

52 dinal data assessing the association between e-cigarette use and respiratory symptoms are lacking.

53 his study cannot establish causality between e-cigarette use and respiratory symptoms.

54 gest a strong association between adolescent e-cigarette use and subsequent cannabis use.

55 In this study, daily e-cigarette use and use of e-cigarettes in 2019 to 2021

56 e-Cigarette use and vaping marijuana (cannabis) are popu

57 shared genetic aetiology between smoking and e-cigarette use, and also with socioeconomic position, e

58 s (ever hookah use, current hookah use, ever e-cigarette use, and current e-cigarette use) among New

59 lung undergo numerous changes in response to e-cigarette use, and disease development will depend on

60 iations of social media use with tobacco and e-cigarette use, and fixed effects analyses investigated

61 I, 1.36-1.63]) as well as cigarette smoking, e-cigarette use, and other tobacco product use overall a

62 e advertising exposure, past 30-day parental e-cigarette use, and the number of best friends using e-

63 tive text message plan, reported past 30-day e-cigarette use, and were interested in quitting in the

64 RATIONALE: Rates of adolescent electronic (e-) cigarette use are increasing, but there has been lit

65 Tobacco smoking and e-cigarette use are strongly associated, but it is curre

66 the biological effects of fourth-generation e-cigarette use are unique compared with those associate

67 cannabis use: aRR, 0.17 [95% CI, 0.03-0.96]; e-cigarette use: aRR, 0.16 [95% CI, 0.03-0.82]) compared

68 moking at wave 5) and using baseline current e-cigarette use as the exposure measure.

69 tion PRS and the main outcome, self-reported e-cigarette use, as well as self-reported smoking initia

70 e-Cigarette use, assessed by ever use, past 12-month use

71 .63 [95% CI, 1.32-5.27]) only when assessing e-cigarette use at baseline.

72 aOR, 4.13 [95% CI, 2.35-7.26]) and initiate e-cigarette use at follow-up (eg, among adolescents repo

73 used NRT, especially for those who initiated e-cigarette use before pregnancy, indicating that replac

74 Self-reported current e-cigarette use behaviors (frequency of use, usual e-cig

75 Comprehensive surveillance of e-cigarette use behaviors among youth is important for i

76 ints by 929 (8.6%) participants, and current e-cigarette use by 270 (2.5%) participants.

77 ss trends in prevalence of current and daily e-cigarette use by US adults and to characterize trends

78 lled levels of NIC inhalation, as occur with e-cigarette use, can induce oxidative lung damage.

79 or demographic, cigarette smoking, and other e-cigarette use characteristics.

80 Incident e-cigarette use, cigarette smoking, other tobacco use, a

81 indicated that the adjusted odds of incident e-cigarette use, cigarette smoking, other tobacco use, a

82 es, the adjusted odds ratio of baseline ever e-cigarette use, compared with never e-cigarette use, wa

83 gn, population, definition and prevalence of e-cigarette use, comparison group (if applicable), cigar

84 In contrast, daily e-cigarette use consistently increased, particularly amo

85 E-cigarette use continues to rapidly escalate in the USA

86 Electronic cigarette (e-cigarette) use continues to rise despite concerns of l

87 We reviewed e-cigarette use (current, former, or never), as assessed

88 e-Cigarette use declined from baseline to 6-month follow

89 These results suggest that although current e-cigarette use decreased during 2019 to 2020, overall p

90 ween 2014 and 2021, the age at initiation of e-cigarette use decreased, and intensity of use and addi

91 l use generally increased, whereas exclusive e-cigarette use decreased, collectively constituting no

92 E-cigarette use did not significantly change from 2023 t

93 linicians should monitor the health risks of e-cigarette use, discourage nonsmokers and adolescents f

94 The weighted prevalence of exclusive e-cigarette use during late pregnancy increased from 0.8

95 s analysis found that, unlike cigarette use, e-cigarette use during late pregnancy was not statistica

96 to adverse neurodevelopmental outcomes, yet e-cigarette use during pregnancy continues to rise due t

97 ancy (aPR 0.95; 95% CI 0.88, 1.02); however, e-cigarette use during pregnancy was associated with hig

98 ed by nicotine, making it highly likely that e-cigarette use during pregnancy will have the same harm

99 linical guidance and public policy regarding e-cigarette use during pregnancy.

100 time-varying and time-lagged associations of e-cigarette use during waves 2-4, with respiratory sympt

101 Self-reported current (past 30-day) e-cigarette use estimates among high school and middle s

102 Nonnicotine e-cigarette use (ever, past 30- and past 7-day, number o

103 Acute exposure to flavored e-liquids or e-cigarette use exacerbates endothelial dysfunction, whi

104 Overall, regardless of e-cigarette use, few adolescents (362 adolescents [4.1%]

105 h aged 12 to 17 years in 2019; prevalence of e-cigarette use, flavor/device combination used, and bra

106 Transitions in e-cigarette use, flavor/device combination used, brand u

107 However, the efficacy and safety of e-cigarette use for this purpose remain poorly understoo

108 icant, increase in the prevalence of current e-cigarette use (from 13.5% [95% CI, 12.3%-14.7%] to 14.

109 nificant increase in the prevalence of daily e-cigarette use (from 4.4% [95% CI, 3.8%-5.1%] to 6.6% [

110 als aged 18 to 20 years who reported current e-cigarette use had never used combustible cigarettes.

111 spiratory and cardiovascular consequences of e-cigarette use has become of increasing interest to the

112 In the past 5 years, e-cigarette use has been increasing rapidly, particularl

113 E-cigarette use has surged, but the long-term health eff

114 Electronic cigarette (e-cigarette) use has been reported to increase the likel

115 Electronic cigarette (e-cigarette) use has gained recent widespread popularity

116 Electronic cigarettes (e-cigarettes) use has increased globally and could poten

117 Furthermore, adverse effects of e-cigarette use have been linked to chronic lung disease

118 nearly 1500 hospitalizations associated with e-cigarette use have been reported in 49 states and the

119 Pulmonary illnesses related to e-cigarette use have been reported, but no large series

120 Vaping and electronic cigarette (e-cigarette) use have grown exponentially in the past de

121 e-Cigarette use (ie, daily use, nondaily use, or no use)

122 years to identify the health consequences of e-cigarette use if we rely only upon human data.

123 states and territories that provided data on e-cigarette use in 2017 (53 states and territories), 201

124 t that most youth who initiated or continued e-cigarette use in 2021 used flavor/device combinations

125 Among those who continued e-cigarette use in 2021, 121 (84.0%) of those who used s

126 E-cigarette use in adolescents is associated with future

127 ine the long-term cardiopulmonary effects of e-cigarette use in humans.

128 D-19 pandemic, it is unclear how patterns of e-cigarette use in the US have changed.

129 However, the prevalence of daily e-cigarette use increased consistently from 1.5% (95% CI

130 om 38.1% (current hookah use) to 58.3% (ever e-cigarette use), indicating substantial false-negative

131 condary analysis stratified by the timing of e-cigarette use initiation, existing users of e-cigarett

132 g initiation, but it remains unclear whether e-cigarette use is associated with continued cigarette s

133 Objectives: To determine whether e-cigarette use is associated with the development of re

134 es of observational studies demonstrate that e-cigarette use is not associated with smoking cessation

135 This is concerning given that e-cigarette use is perceived as less harmful than conven

136 However, paradoxically, e-cigarette use is rapidly growing among nonsmokers, inc

137 Rationale: Electronic cigarette (e-cigarette) use is highly prevalent among young adults.

138 ilable evidence on the risks and benefits of e-cigarette use, large, randomized, controlled trials ar

139 osure, increasingly occurring as a result of e-cigarette use, may induce epigenetic changes that sens

140 Frequency of alcohol, cannabis, and e-cigarette use (measured in days) and any binge drinkin

141 of past 30-day cigarette, cigar product, or e-cigarette use, measured using geographically represent

142 sults suggest that like combustible tobacco, e-cigarette use might increase chemotherapy resistance,

143 ed when dual users transitioned to exclusive e-cigarette use; NNAL levels decreased by 96%, from a me

144 In this cohort, a reduction in e-cigarette use occurred independently of COVID-19 stay-

145 16.0%-24.8%) of middle school users reported e-cigarette use on 20 to 30 days within the past 30 days

146 neurodevelopmental consequences of maternal e-cigarette use on adult offspring behavior and neuroimm

147 Women reported current and former e-cigarette use on baseline and follow-up questionnaires

148 uired to understand the long-term effects of e-cigarette use on breath odour.

149 The effects of e-cigarette use on cardiopulmonary endpoints in adolesce

150 ue-specific epigenetic effects of tobacco or e-cigarette use on DNA methylation (DNAme) in over 3,500

151 have been used to study the effects of naive e-cigarette use on various organ systems; however, almos

152 garettes only, former smokers with long-term e-cigarette use only, former smokers with long-term nico

153 29, 95% CI 1.19 to 1.39, p < 0.001) and ever e-cigarette use (OR = 1.24, 95% CI 1.14 to 1.34, p < 0.0

154 2) recorded significant increases in current e-cigarette use over the same period.

155 age-adjusted prevalence of current and daily e-cigarette use overall and by participant characteristi

156 outweigh any negative oral health impacts of e-cigarette use, particularly in the short term.

157 e-cigarette use (past 30 days), flavor/device combinatio

158 ce studies should further assess nonnicotine e-cigarette use patterns and regulations, and prevention

159 Prevalence of e-cigarette use peaked in 2019 and then declined.

160 , whereas female individuals reported higher e-cigarette use prevalence than male individuals; (2) ru

161 han e-cigarettes; and (3) nicotine pouch and e-cigarette use prevalence was higher among 12th vs 10th

162 There was no association between e-cigarette use prior to pregnancy and combustible cigar

163 These findings suggest that e-cigarette use remained common during the COVID-19 pand

164 erall prevalence, frequent use, and flavored e-cigarette use remained high.

165 se acute results indicate that cigarette and e-cigarette use results in significantly different breat

166 strong association at the individual level, e-cigarette use seems to have had a minimal association

167 ameters were significantly higher during the e-cigarette use sessions with 3% or 2.4% nicotine concen

168 These variables included smoking history, e-cigarette use, sociodemographics, lifestyle factors, i

169 tobacco use behaviors stratified by current e-cigarette use status.

170 t (past 30-day) vaping of CBD overall and by e-cigarette use status.

171 With the rise of e-cigarette use, teen nicotine exposure is becoming more

172 Two cohorts were defined based on e-cigarette use: "Vapers Cohort" (N = 491) who used e-ci

173 ation on the cardiopulmonary consequences of e-cigarette use (vaping) in adolescents, to guide therap

174 With the prevalence of e-cigarette use (vaping) increasing worldwide, there are

175 esearch indicates that electronic cigarette (e-cigarette) use (vaping) among adolescents is associate

176 dels were used to examine the association of e-cigarette use vs NRT with smoking abstinence.

177 he per-wave prevalence of former and current e-cigarette use was 15.2% and 5.6%, respectively.

178 The prevalence of current e-cigarette use was 4.4% (95% CI, 4.3%-4.5%) in 2017, wh

179 The age-standardized prevalence of current e-cigarette use was 6.9% (95% CI, 6.7%-7.1%), with almos

180 Current e-cigarette use was also associated with lower 30-day (O

181 Tobacco use history and patterns of e-cigarette use was also examined.

182 Current e-cigarette use was also negatively associated with 30-d

183 In this study, habitual e-cigarette use was associated with a shift in cardiac a

184 Baseline e-cigarette use was associated with greater likelihood o

185 In this cohort study, daily e-cigarette use was associated with greater odds of ciga

186 Daily vs nondaily e-cigarette use was associated with greater overall ciga

187 e-Cigarette use was associated with greater risk for sub

188 Current e-cigarette use was associated with higher odds for any

189 e cohort of young adults, former and current e-cigarette use was associated with higher odds of devel

190 Former e-cigarette use was associated with higher odds of devel

191 Among cigarette experimenters (1 puff), ever e-cigarette use was associated with higher odds of ever

192 While e-cigarette use was associated with higher odds of quit

193 ared with never use of e-cigarettes, current e-cigarette use was associated with slightly lower fecun

194 Current e-cigarette use was associated with slightly reduced fec

195 evalence of current (past 30 days) and daily e-cigarette use was estimated for each year, and changes

196 slight decrease in the prevalence of current e-cigarette use was found between 2018 and 2020; this de

197 In 2019, the prevalence of self-reported e-cigarette use was high among high school and middle sc

198 the primary fully adjusted models, baseline e-cigarette use was independently associated with progre

199 smokers of cigarettes (100 cigarettes), ever e-cigarette use was negatively associated with 30-day (O

200 Nondaily e-cigarette use was not associated with cigarette discon

201 oduct-specific analyses showed that baseline e-cigarette use was positively associated with combustib

202 Current e-cigarette use was positively associated with ever smok

203 Ever e-cigarette use was reported by 502 (24.0%), of whom 201

204 tory of established combustible tobacco use, e-cigarette use was statistically linked to more frequen

205 ne ever e-cigarette use, compared with never e-cigarette use, was 1.81 (95% CI, 1.03 to 3.18) for con

206 -level patterns in the prevalence of current e-cigarette use were heterogeneous, with states like Mas

207 dults (aged >=25 years) who reported current e-cigarette use were more likely to report former or cur

208 erification of abstinence, and definition of e-cigarette use) were also not associated with the overa

209 aged 13 to 17 years who reported past 30-day e-cigarette use, were interested in quitting within 30 d

210 on genetic vulnerability to both smoking and e-cigarette use, which may reflect a broad risk-taking p

211 To investigate the associations of e-cigarette use with chronic bronchitis symptoms and whe

212 Recent clinical trials suggest that e-cigarette use with counseling may be effective in redu

213 Association of e-cigarette use with quitting did not significantly diff

214 no statistically significant associations of e-cigarette use with wheeze after adjustment for cigaret

215 e association of youth electronic cigarette (e-cigarette) use with subsequent cigarette smoking initi

216 tioned from exclusive cigarette to exclusive e-cigarette use, with a 92% decrease in NNAL, from a mea

217 here was a consistently higher prevalence of e-cigarette use, with more than 18.6% reporting current

218 equency of combustible cigarette smoking and e-cigarette use within the past 30 days (0 days [none],